Dermapharm Holding SEFRA:DMP 87 Forward Dividend Yield % is 1.90% as of Jun. 27, 2026. GuruFocus rates FRA:DMP with a GF Score™ of 87/100 and a GF Value™ of €39.11 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 504 Drug Manufacturers companies, Dermapharm Holding SE ranks worse than 54.96% on this metric.
As of today (2026-06-27), the Forward Annual Dividend Yield of Dermapharm Holding SE is 1.90%.
As of today (2026-06-27), the Trailing Annual Dividend Yield of Dermapharm Holding SE is 1.95%.
FRA:DMP's Forward Dividend Yield % is ranked worse than 54.96% of 504
companies
in the Drug Manufacturers industry
Industry Median: 2.08
vs FRA:DMP: 1.90
During the past 12 months, Dermapharm Holding SE's average Dividends Per Share Growth Rate was 2.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -25.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -0.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dermapharm Holding SE was 41.30% per year. The lowest was -25.40% per year. And the median was 4.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Dermapharm Holding SE (FRA:DMP) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Dermapharm Holding SE Forward Dividend Yield % Related Terms
FRA:DMP vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermapharm Holding SE Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Dermapharm Holding SE's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 1.90% mean?
Dermapharm Holding SE (FRA:DMP) has a Forward Dividend Yield % of 1.90% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Dermapharm Holding SE and its competitors. According to the industry distribution chart, Dermapharm Holding SE ranks #277 out of 504 companies in the Drug Manufacturers industry, placing it in the top 55%.
Is Dermapharm Holding SE's Forward Dividend Yield % too high?
Dermapharm Holding SE's current Forward Dividend Yield % is 1.90%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.08. Dermapharm Holding SE's value of 1.90% is 8.7% below this industry median. Based on the distribution chart, Dermapharm Holding SE ranks #277 out of 504 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Dermapharm Holding SE has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dermapharm Holding SE ranks #277 out of 504 companies for Forward Dividend Yield %. This places Dermapharm Holding SE in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. Dermapharm Holding SE's value of 1.90% is 8.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dermapharm Holding SE's current Forward Dividend Yield % of 1.90% is 8.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Dermapharm Holding SE and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dermapharm Holding SE's current Forward Dividend Yield % is 1.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Based on GuruFocus' analysis, Dermapharm Holding SE (FRA:DMP) is currently considered Modestly Overvalued. The stock's GF Value™ is €39.11, compared to a current price of €46.25 — trading 18.3% above its estimated fair value. The current Forward Dividend Yield % is 1.90% and 8.7% below the Drug Manufacturers industry median of 2.08. Dermapharm Holding SE's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Dermapharm Holding SE (FRA:DMP), the current Forward Dividend Yield % is 1.90% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dermapharm Holding SE (FRA:DMP) Overvalued in 2026?
Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued.
The current stock price of €46.25 is trading 18.3% above its estimated GF Value™ of €39.11.
GuruFocus considers Dermapharm Holding SE to be Modestly Overvalued.
Key valuation signals for FRA:DMP:
Forward Dividend Yield %: 1.90%
GF Value™: €39.11 vs. price of €46.25 (18.3% above fair value)
Industry Position: 8.7% below the Drug Manufacturers median (#277 of 504)
No single metric tells the full story. See the FRA:DMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
87GF Score
Get the complete analysis for FRA:DMP
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DMP has been successfully added to your 